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While provocative findings from large epidemiological studies suggest that mental disorders and/or elevated psychiatric symptoms are independent risk factors for the incidence and recurrence of coronary heart disease (CHD), other studies do not replicate this somewhat startling finding. [1] [2] [3] This research has been characterized by incomplete adjustment for confounders, by wide variation in the assessment of mental disorders, and by inconsistent inclusion of multiple mental disorders and overlapping symptom clusters. For incident CHD, the most convincing evidence comes from prospective studies linking a diagnosis of depression or the presence of elevated depressive symptoms with later occult CHD. 3 And, although there have been tantalizing glimpses of associations of other types of mental disorders, such as alcohol/substance-use disorder, anxiety, and schizophrenia, with incident CHD, there are a paucity of studies examining this risk. Indeed, we conducted a preliminary search of the prospective epidemiological literature on the association of mental disorders with incident CHD and found that out of 123 results retrieved, approximately 60% focused uniquely on depression, 10% on alcohol/substance use disorder, 11% on anxiety or posttraumatic stress disorder (PTSD), and 14% on psychosis or schizophrenia. Thus, outstanding questions about the nature and consistency of the association of specific types of mental disorders--other than depression--and incident CHD remain.
In this issue of Circulation, Gale et al. provide results from a cohort of over 1 million adult men born in Sweden from 1950-1976 who were followed for 22 years for incident CHD 4 .
Importantly, all were systematically assessed at conscription (around 18 years) for multiple psychiatric disorders by trained psychiatrists, including alcohol-related disorders, other nonaffective psychoses, schizophrenia, bipolar disorder, depressive disorder, neurotic disorders, adjustment disorders, personality disorders, and other substance use disorders. This is one of the alcohol/substance-use disorder, anxiety, and schizophrenia, with incident CHD, th th ther er re ar are e e a a a paucity of studies examining this risk. Indeed, we conducted a preliminary search of the pr ros os spe pe pect ct ctiv iv ive e e e ep pid dem em emio i logical literature on the asso so soci iation of menta ta al l diso so ord rd rders with incident CHD an nd d d fo f und that at o out ut u o of f f 12 123 3 3 re re resu su sul lt lts s re re ret tr trie ieve ve ed, a a app prox xi xim mat te tel ly ly 6 6 60 0% % f f foc c cus used ed ed u u uni niqu qu quel ely y on on on d d de ep epr re ress ss sio io on, n a 10 0 0% % % on on on a alc lc coh oh ohol ol/ /s su ub ubst sta an ance ce c use se se d d dis is isor or ord der er r, , 11 11 11% % % on on on a a anx x xie e ety ty t o o or r r po po post st s tr tr rau au uma ma mat t tic c c st stre re ress ss s d dis is iso o orde de er (P (P ( T T TSD D) D), and 14% on p p psy sy sych ch hos os osis is s o o or sc sc schi hi hizo zo oph ph phre re eni nia. a. a. T T Thu hu hus, s, s ou ou outs ts sta ta and nd din in ing g g qu qu ques es esti ti t on n ns s a a abo bo bout ut ut t the he e n n nat at a ur ur ure e e and a first and largest population-based studies with such a comprehensive assessment of mental disorders that adequately accounted for secular time trends and potential confounders.
Interestingly, Gale et al. showed that men who were diagnosed with any early onset mental disorder or who had a psychiatric hospitalization during the follow-up period of 22 years had an increased risk of incident CHD even after adjustment for numerous confounders. Of note, those with a depressive disorders diagnosis in early adulthood were only at marginally increased CHD risk after adjustment for standard CHD risk factors, and adjustment for potential explanatory variables such as socioeconomic status, IQ, and risky alcohol intake. Although the study by Gale and colleagues is impressive and provides evidence of heightened incident CHD risk among those with mental disorders, we highlight for readers some issues that warrant consideration in understanding mental disorders and cardiovascular risk.
First, the study by Gale and colleagues was conducted in Sweden, a country that has a single payer system, with no apparent disparities in mental and physical health reimbursements. 5 This is in sharp contrast to the United States health care system, where reimbursements for mental health or behavioral services are not quite on par with reimbursements for physical health services, despite several recent policy changes. 6 Further, these two high-income countries differ markedly in the degree of income inequality and national health profiles, with the US faring much worse in national health status indicators despite a high level of per capita spending on health care. 7 Thus, the extent to which the findings from Sweden should be accepted as representative of the influence of mental disorders on CHD risk in the United States is unclear. It is also possible that disparities in mental health services will result in under-treatment of those with mental disorders, particularly those from disadvantaged groups, which in turn would accentuate CHD risk among these subgroups. Also Gale and colleagues focused exclusively on hose with mental disorders, we highlight for readers some issues that warrant co ons nsid id i er er rat at atio io ion n n in in understanding mental disorders and cardiovascular risk.
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men, so the extent to which these findings can be generalized to women is unclear. We cannot assume that risk factors for CHD operate the same for men and women. 8 Next, we have to caution readers that there are many potential explanations left to be explored, before concluding that this association might be causal. For example, it is quite possible that cardiotoxic side effects associated with the use of typical and atypical antipsychotic medications that block repolarizing potassium currents in vitro and prolong the QT interval, might explain the increased CHD risk among those diagnosed with mental disorders. 9 Similarly, metabolic effects of psychotropic medication use might be key contributors of increased CHD risk through weight gain. 10 Other explanations for this observed correlation include the presence of the S allele of the serotonin transporter (5-HTT) gene-linked polymorphic region, which increases the risk for both depression and CHD risk. proposed to explain the depression-CHD association include platelet reactivity, inflammation, of the S allele of the serotonin transporter (5-HTT) gene-linked polymorphic regi gi ion n n, wh wh whic ic ich h h ncreases the risk for both depression and CHD risk. 11 Other potential intriguing explanations n ncl cl lud ud ude e e th th the e e un un ndi iag ag agno nosed presence of supraventric ic icul ula ar tachycardia as, s s wh wh hic ic ich h are mistakenly ex xpe perienced as as a anx nx xie ety ty y o o or r pa pa pani ni nic c sy sy ym mp mpt to om m ms b b by pati ie en nts. . . O On One e e f fi fina nal l e ex exam am mpl ple e of of of a a a p pos os ossi si sibl bl ble e e co co comm mm mmon o ca aus us use e e fo fo f r r th th his is is a ass ss soc c cia iat ti ion on n i is th th the e il il illi li lici ci cit t u us use e e of of of coc oc ocai ai ine ne e, , wh wh whic ic ich h h is s s k k kn no nown wn wn t t to o c ca caus us use e bo bo b th th th c cor r ron n nar ary y y vasospasm an an nd d d ea ea earl rl rly y y CH CH CHD, D, D, a a as s s we we well ll l a a as s pa pa para ra rano no noia ia ia, , p p pan an anic ic ic, an an and d d la la ast st tin in ing g g an an anxi xi xiet et ety y y di di d so so ord rd der er ers. s. s autonomic imbalance, sleep architecture disruption, circadian rhythm disruption anabolic/catabolic hormonal imbalance, and many others. 13 However, we have little direct human evidence that any of these are causally implicated in the pathogenesis associated with mental disorders that precede incident CHD. Mental disorders might also influence CHD risk through its effects on a patients' behaviors, such as weight gain 14 (even independent of that potentially caused by psychotropic medication use), smoking, or other CHD accelerating risks, such as non-adherence to a medication regimen 15 and/or to other lifestyle recommendations. 16 Indeed, it is reasonable to expect that a patient with a mental disorder will have low compliance with preventive cardiology recommendations. 15 In addition, there may be disparities in the way the healthcare system behaves towards patients with mental disorders, and these differences -for example, the treatment they receive -may lead to worse outcomes. 17 More likely is these systemic, biological and behavioral mechanisms interact with one another in a complex system with positive and negative feedback mechanisms.
We have recently been intrigued by one specific behavior that we all engage in that could be implicated in the complicated connections between mental disorders and cardiovascular risk:
sleep. Over 30% of our adult lives will be spent asleep, yet most of the mechanistic research on mental health and cardiovascular risk has focused on activities, behaviors, and biological processes that occur while awake. For example, while sleep disturbances, such as short sleep duration, and obstructive sleep apnea are associated with incident CHD, 18, 19 only a handful of studies have examined if this particular mechanism is implicated in the relation of mental disorders with CHD risk. This dearth exists, despite extensive research on the intimate connection and bidirectionality of sleep disturbances and mental disorders such as depression. 20 Chronic sleep disturbances lead to sleep architecture disruption and circadian rhythm disruption, he healthcare system behaves towards patients with mental disorders, and these e di d diff ff f er r ren en ence ce ces s s --f for example, the treatment they receive -may lead to worse outcomes. 17 More likely is these y yst st tem em emic ic ic, bi bi biol ol o og gic ic ica al al and behavioral mechanisms s s i in nt teract with on ne e e anot ot the he her r in a complex system w with h h positive an and d d n ne nega ga ati ive ve ve f f fee ee eed db dbac ac ck k k m m mec c chan n nis s sms. .
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which in turn might increase risk for CHD through the disruptions that occur for endothelial function, inflammatory regulation, and/or metabolic regulation, among other suggested pathways. 21 Clinicians and scientists have observed the heightened risk for CHD among those with a mental disorder since 1937. 22 We gr grea ea ate te ter r r f fo focu cu cus on n a a an nd nd assessment of established b b be e eha ha avioral risk fact ct c ors s fo fo for r r CHD such as smoking an nd d d ph p ysical i ina nac ct c i i ivit it i y y y, t t tha ha hat t t of of oft te ten n co co co-o -o occ c cur w w wi i ith me me menta al al d dis isor or orde der rs, wo woul u u d d be be e i in n n th the e e be be best st t int nt nter eres es est t of h hes es ese e pa pa pati tien en nts ts ts. . Se Se ec co ond nd d, c ca card r io io olo lo ogi gi gist st sts s s sh sh hou ou uld ld ld exp xp xpe ec c ct g g gre e eat at ter er er d dif if ffi fi f c cu ult lt tie ie ies s wi wi with th a a any ny ny m m med ed edica a atio io on n adherence am m mon on ong g g th th thes es se e pa pati ti tien en ents s s, , an an a d d d ag ag ggr gr gres es essi si sive ve ve m m man an anag agem em emen en ent t of of of m med ed edic ic icat at atio io ion n n us us se e e sh sh shou ou ould l be know that mental disorders mark a 20% to 80% increase in incident CHD risk and death. We don't yet have the research or the tools to effectively know why, and what to do about this puzzling association. Perhaps its time to consider a more complex systems approach to CHD risk identification in patients with mental disorders that focuses on processes that occur while asleep.
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